|
|
| 479 | Development of in vitro Models for Studies on HIV Neuropathogenesis
J Wang*, and D Gabuzda
Dana-Farber Cancer Inst., Boston, MA, USA |
| 480 | Measures of Human Lymphocyte Transmigration into Brain in a Murine Model of HIV-1 Encephalitis
R L Mosley*, M L Zelivyanskaya, H Dou, T B Lewis, L Y Poluektova, M Uberti, M Mellon, A Nelson, M D Boska, and H E Gendelman
Univ. of Nebraska Med. Ctr., Omaha, USA |
| 481 | Effects of Statins on the Transmigration of Monocytes and T Cells across the Blood Brain Barrier
A Mengistu*, E Acheampong, G Nunnari, E Argyris, M Kalayeh, K J Williams, R J Pomerantz, and M Mukhtar
Thomas Jefferson Univ., Philadelphia, PA, USA |
482
 | The Peripheral Benzodiazepine Receptor Can Be Used to Quantify Macrophages In SIV Encephalitis
S Venneti*, and C A Wiley
Univ. of Pittsburgh Sch. of Med., PA, USA |
| 483 | Human Progenitor Derived Astrocytes Phagocytized HIV-1 through Mannose Receptor
J R Trujillo*, P Jensen, D Maric, and E O Major
NINDS, NIH, DHHS, Bethesda, MD, USA |
| 484 | HIV-1 Enters Primary Human Brain Microvascular Endothelial Cells by a Mechanism Involving Cell-Surface Proteoglycans Independent of Lipid Rafts
E G Argyris*, E Acheampong, G Nunnari, M Mukhtar, K J Williams, and R J Pomerantz
Thomas Jefferson Univ., Philadelphia, PA, USA |
| 485 | Molecular Analysis of Blood and Cerebrospinal Fluid Treponema pallidum in Neuroinvasion Compared to Neurosyphilis in HIV-infected Individuals
C M Marra*, H Bashiri, A Centurion, J Mittler, and S A Lukehart
Univ. of Washington, Seattle, USA |
486
| Predominantly Concordant CCR5 Chemokine Receptor Utilization in CSF and Plasma in a Survey Sample of HIV-infected Subjects
S Spudich*1, A Nilsson1, K Onstott1, W Huang2, J Whitcomb2, and R W Price1
1San Francisco, CA, USA and 2South San Francisco, CA, USA |
487
| HIV-1-induced Synaptic Dysfunction and Its Attenuation by Memantine in a Murine Model of HIV Encephalitis
E R Anderson, L Poluektova, H E Gendelman, and H Xiong*
Univ. of Nebraska Med. Ctr., Omaha, USA |
| 488 | Neuroprotective Effects of Non-immunosuppressive Immunophilin Ligands in Antiretroviral Toxic Neuropathy is Mediated by hsp70 Pathway
J Schneider, S Keswani, M Polley, H Liang, and A Hoke*
Johns Hopkins Univ., Baltimore, MD, USA |
